In the present study, we provided the evidence that the stabilization of Bcl-2 by its phosphorylation at Serine 87 via PXN-mediated ERK activation promoted tumor invasion and poor patient outcome in colorectal cancer. The gene discussed is BCL2; the disease is neoplasm.